Ponenciaencongressomundialde Cancer

The expanding role of primary
care in cancer control

A Lancet Oncology Commission
Greg Rubin
Professor of General Practice and Primary Care
‘Health services striving
for affordable cancer care
seek optimal models of
care delivery, which may
require the re-engineering
of some deeply held socio-
medical cultural practices’
∂
The Lancet Oncology: The
expanding role of primary care in
cancer control
36 authors with clinical and academic

cancer expertise; backgrounds in primary
care, public health, oncology, psychology,
health policy.
∂
Aim: to distil the evidence for the
effectiveness of interventions for cancer
control based in primary care at each
stage of the cancer journey and to
consider how cancer care might be
delivered differently in the future.
Focus: high-income countries with

universal health care systems
Integrated care is vital
if we are to optimise
∂
the quality and
outcomes of care
Action points for integrated
cancer care
• Care pathways are key to integrated care, but effective lines of
communication need to be established to ensure their success
• Cross-sector education is central to integrated care and should extend
beyond clinical content to include care pathways, systems, and quality
improvement ∂
• Patient navigators show promise as a means to enhance integrated care,
and their contribution should be further assessed
• Health-care providers and policy makers should adapt evidence-based
models and tools to improve integration between primary and specialist care
for each phase of cancer control
• These models and tools should be introduced with strategies for
implementation, adoption, and sustainability that have proven effectiveness
∂
Primary prevention offers

considerable potential for
reducing incidence of cancer
but is not well implemented
∂
There are variations and

inequalities in uptake of
cancer screening
Prevention: action points
• Primary care needs to move beyond its focus on smoking and alcohol
use in primary prevention, and engage effectively in initiatives to
promote physical activity and reduce obesity.
• Primary care should prepare itself for growth in genomic information
and how this information can be incorporated
∂ with lifestyle and other
factors to develop individualised preventive strategies.
• Population-level early diagnosis and screening strategiesneed to fully
engage primary care to maximise their potential
Patient-related delays are
an important contributor to
overall time to diagnosis
∂
Symptoms that could ∂be cancer
are common in primary care,
but cancer is rare
Symptomatic diagnosis: action
points
• Advances in the epidemiology of cancer symptoms in primary care allow more
accurate risk assessment and selection of patients who need urgent
investigation
• Internationally, evidence for the epidemiology of symptoms should be
systematically applied to inform diagnostic pathways aimed at reducing time to
cancer diagnosis
• Risk assessment tools and electronic ∂ clinical decision support could potentially
improve early diagnosis of many cancers in primary care, but trials are needed
to study their efficacy
• If research confirms their usefulness, such tools should be rapidly incorporated
into the clinical software used by primary-care physicians
• Certain cancers might be inherently more difficult to diagnose than others in
primary care, and the development of accurate biomarkers is needed to support
early diagnosis
• Effective biomarkers for early diagnosis, both in symptomatic patients and in
those with a high baseline risk, are a research priority
Follow-up care for
cancer requires
expertise in managing
its wider physical and
psychological sequelae
∂
People will continue to ∂
die as a result of cancer
and wish to do so in
comfort and at home
Action points: survivorship and
palliative care
• Primary care, with its holistic approach, has a potentially important role in cancer
survivorship care, but the its role in such care needs to be clearly defined
• New models of cancer follow-up care should draw on the principles that apply
for other long-term conditions
• After further development to arrive at the optimal model, plans for survivorship
care should become a feature of follow-up∂ care
• Evidence suggests that primary-care-based and shared-care models of follow-
up can be just as effective as secondary-care-led follow-up for breast and colon
cancers; good communication between all care providers and clear guidance for
primary-care professionals are key
• Primary-care physicians should participate in provision of palliative care; they
should be supported, provided with high-quality training, and adequately
resourced to do so
• All patients receiving palliative care should have an advance care plan, which
should include a plan for their clinical care
What impact have we had?
• Hard copies were sent to 50 key opinion leaders in the countries
represented by the author group. A number of these KOLs have
volunteered that they have read it and are using it, including the Health
Secretary of one country!
• The Commission is heavily influencing a national cancer research
strategy in UK as well as a European cancer strategy.
• In Denmark, GPs formed a national ‘virtual journal club’ to read and
summarise each chapter. ∂
• In Australia, there is a national move to integrated care, as well as state
and federal programmes for models of shared survivorship care.
• Canada’s first cancer care conference will include a session on the role
of primary care in cancer diagnosis.
• The Commission is informing models of shared care in 2 Indian states
34 citations (Google Scholar) since publication in
October 2015
Greatest progress? Least progress?
Integrated care models Biomarkers for diagnosis
Research agendas Novel referral pathways for
CTYA cancer
Primary care promotion of Incorporating genomic
screening uptake information into assessment
of the symptomatic patient
Integrated models of follow- ∂ Lifestyle interventions in
up care primary care
Audit and performance Advance care plans
feedback
Existing health care funding systems represent an

important barrier to change. Can they change to provide
the right incentives for integrated care?
In summary…..
• Cancer is placing increasing demands on the health
care systems of high-income countries
• There is much that general practice can contribute to
meet this, given…
• Better access to diagnostic services
∂
• Care pathways that integrate primary and specialist
care services
• Resources to support a more extended role
• Continuing professional development and support
• As expert generalists, GPs can bring a dimension to
many aspects of cancer care that enhances both its
clinical quality and the patient experience.
Acknowledgments
For use of images:
• Allemani et al. The Concord-2 study. The Lancet 2015
• Macmillan Cancer Support
• UPCON, Manitoba
• Medx GmbH ∂
• NHS Improvement (Cancer): Innovation to Implementation (2013)
• Wonford Green Surgery
Conflicts of interest
GR provides consultancy advice to Medx GmbH and Dr Falk
pharmaceuticals
He holds current research grants from CRUK and the DH Policy
Research Programme

Ponenciaencongressomundialde Cancer

Uploaded by

Copyright:

Available Formats

Ponenciaencongressomundialde Cancer

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Ponenciaencongressomundialde Cancer

Uploaded by

Copyright:

Available Formats

The expanding role of primary

care in cancer control

36 authors with clinical and academic

Focus: high-income countries with

Primary prevention offers

There are variations and

Existing health care funding systems represent an

You might also like